| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $271.1M | -40.1% |
| Cost of Revenue | $225.1M | -16.6% |
| Gross Profit | $46.0M | -74.9% |
| R&D Expense | $13.4M | -25.7% |
| SG&A Expense | $55.8M | -21.6% |
| Operating Income | -$378.2M | -793.6% |
| Pre-tax Income | -$387.2M | -2665.8% |
| Income Tax | $2.4M | +39.7% |
| Net Income | -$389.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $156.9M | -29.0% |
| Accounts Receivable | $35.3M | -67.7% |
| Inventory | $38.2M | -19.6% |
| Current Assets | $242.1M | -40.9% |
| Total Assets | $406.7M | -54.6% |
| Current Liabilities | $62.0M | -43.7% |
| Long-term Debt | $65.5M | -31.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $32.9M | -27.8% |
| Capital Expenditures | $37.4M | -56.6% |
| Investing Cash Flow | -$37.4M | +56.6% |
| Financing Cash Flow | -$58.1M | -147.6% |
| Free Cash Flow | -$4.6M | +88.8% |
| -3012.5% |
| EPS (Basic) | -$4.73 | -2882.4% |
| EPS (Diluted) | -$4.73 | -2882.4% |
| Total Liabilities |
| $171.2M |
| -39.0% |
| Stockholders' Equity | $235.5M | -61.7% |